Search

Your search keyword '"Geyer, Charles E."' showing total 29 results

Search Constraints

Start Over You searched for: Author "Geyer, Charles E." Remove constraint Author: "Geyer, Charles E." Database Journals@OVID Remove constraint Database: Journals@OVID
29 results on '"Geyer, Charles E."'

Search Results

1. Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2–Positive Breast Cancer: Analysis of the NSABP B-31 Trial

2. Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5

3. Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

4. Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

5. Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

6. Predicting Degree of Benefit From Adjuvant Trastuzumab in NSABP Trial B-31

7. Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer

8. Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2− Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group

10. Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer

14. A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: Updated efficacy and biomarker analyses

20. Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer

22. Sequential Preoperative or Postoperative Docetaxel Added to Preoperative Doxorubicin Plus Cyclophosphamide for Operable Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27

24. Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31

25. Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

Catalog

Books, media, physical & digital resources